Cancer progression is associated with the deregulation of many genes involved in multiple pathways responsible for controlling cellgrowth and differentiation such as:

DNA repair processes. Identification of antitumor activity of new drugs as well as the investigation of drugs in several experimental settings is the key to improve the clinical success of investigational drugs/combination efficacy therefore addressing unmet medical needs in cancer treatment.